Tuberculosis care does not end at treatment completion- a perspective from tuberculosis survivors
Lancet Infect Dis
.
2021 Jul;21(7):896-897.
doi: 10.1016/S1473-3099(20)30941-5.
Epub 2021 Feb 25.
Authors
Ingrid Schoeman
1
,
Zolelwa Sifumba
2
Affiliations
1
TB Proof, Pretoria 0184, South Africa. Electronic address: ingrid.tbproof@gmail.com.
2
TB Proof, Pretoria 0184, South Africa.
PMID:
33640078
DOI:
10.1016/S1473-3099(20)30941-5
No abstract available
Publication types
Comment
MeSH terms
Antitubercular Agents / therapeutic use
Humans
Survivors
Tuberculosis* / drug therapy
Substances
Antitubercular Agents